Location: Boston
Date:
Event description: DATE: June 5 (in person) June 6 & 7 (virtual) The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners across the lifescience and healthcare industry. Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme. Our Novotech clinical team have almost 20 years’ experience working on 500+ early phase studies, making us an exceptionally experienced local provider within the Australian & New Zealand market and a partner of choice for many international biotech companies.
This event has concluded
Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.
Have a question or want to continue the conversation?
Meet Our Team
John Moller
Barry Murphy
Andy Liu
Plus team members from our Novotech China, Novotech DDC and US BD teams